| Scientific Name |
DURVALUMAB
|
|---|---|
| Brand Name |
IMFINZI
|
| Risk |
Risk of Overlap Syndrome of (Myocarditis, Myositis, and Myasthenia Gravis)
|
| Safety Communication for Healthcare Professionals |
|